Maize lethal necrosis disease (MLN) was first diagnosed in eastern Africa in the 2010's and is a big threat to their maize-based agri-food systems with estimated losses amounting to US$261 million in Ethiopia and US$198 million in Kenya. This paper reviews the agronomic and policy options to contain MLN and comparatively analyzes the feasibility of using maize-bean rotations and MLN-tolerant germplasm as key alternative strategies for managing MLN. Results from crop simulation and economic surplus models are used to make assessments on what strategy offers the most realistic MLN control approach given the circumstances of smallholder production in Kenya and Ethiopia. The paper finds that although maize-legume rotations are sound agronomic recommendations and are crucial for long term maize production system viability, their widespread application over large geographic areas for MLN control is economically challenging given that maize is a preferred staple. We conclude that scaling MLN-tolerant germplasm proves highly viable with estimated multiplier benefits of US$245-756 million in Ethiopia and US$195-678 million in Kenya, and benefiting up to 2.1 million people in Ethiopia and 1.2 million in Kenya. Given that the threat of MLN is present and ongoing, the food and economic security of maize-based agrarian economies in eastern Africa will critically depend on the successful mainstreaming of MLN tolerance in their maize seed systems.
Agricultural Systems – Elsevier
Published: May 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera